Suchergebnisse - "Shi, Yuankai"

PubPharm (531)

51

Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)

enthalten in: BMC medicine | 2023

von Shi, Y. | Chen, J. | Zhang, H. | +30

52

Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)

enthalten in: BMC medicine | 2023

von Shi, Y. | Chen, J. | Zhang, H. | +30

53

Association of immune-related adverse events and efficacy in advanced non-small-cell lung cancer : a systematic review and meta-analysis

enthalten in: Immunotherapy | 2023

von Zhou, Y. | Chen, H. | Tang, L. | +5

54

Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Feng, Y. | Tang, L. | Wang, H. | +5

55

Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma : a multicenter, single-arm, phase 2 study

enthalten in: The Lancet regional health. Western Pacific | 2023

von Shi, Y. | Qin, X. | Peng, X. | +41

56

Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer

enthalten in: Frontiers in immunology | 2023

von Chen, D. | Li, L. | Wang, M. | +8

57

Genetic Profiling of Diffuse Large B-Cell Lymphoma : A Comparison Between Double-Expressor Lymphoma and Non-Double-Expressor Lymphoma

enthalten in: Molecular diagnosis & therapy | 2023

von Chen, H. | Qin, Y. | Liu, P. | +8

58

Landscape of the clinical development of China innovative anti-lung cancer drugs

enthalten in: Cancer pathogenesis and therapy | 2023

von Shi, Y.

59

Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018)

enthalten in: Cancer pathogenesis and therapy | 2023

von Shi, Y. | Chen, H. | Qin, Y. | +17

60

Cancer PathogenesisandTherapy : A new journal, a new inspiration

enthalten in: Cancer pathogenesis and therapy | 2023

von Shi, Y. | Kerr, D.